Off-pump vs on-pump surgery in patients with stable coronary artery disease

ISRCTN ISRCTN59539154
DOI https://doi.org/10.1186/ISRCTN59539154
Secondary identifying numbers 1926/01/114
Submission date
21/02/2008
Registration date
10/03/2008
Last edited
20/12/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Prof Whady Hueb
Scientific

Av. Dr. Eneas Carvalho Aguiar 44 AB
Sala 114
Sao Paulo
05403000
Brazil

Study information

Study designRandomised controlled comparative trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleA randomised comparative study of patients undergoing myocardial revascularisation with or without cardiopulmonary bypass surgery
Study acronymMASS III
Study hypothesisThe aim of the MASS III Trial is to compare medical effectiveness, safety, cerebral injury, quality of life, cost-effectiveness of coronary surgery with (on-pump) or without (off-pump) cardiopulmonary bypass.
Ethics approval(s)Institutional Review Board (Comissão de Ética para Análise de Projetos de Pesquisa - CAPPesq) approved on 19/10/2001.
ConditionCoronary artery disease
InterventionTrial operators were required to perform optimum coronary revascularisation in accordance with the current best practices. The surgery was performed by physicians experienced in both on-pump and off-pump bypass surgery techniques. Surgical access to the heart was through a standard median sternotomy in all cases. All incisions and closure techniques were the same for both groups, limiting variability and maintaining blinding of group assignment for patients, family and cardiologists. A cell saver reservoir (COBE Cardiovascular, Inc., USA) was spun down and returned to all patients when the quantity was sufficient.

Off-pump strategies: Off-pump surgery used the Octopus stabiliser described in detail elsewhere. In brief, the distal ends of the two suction arms of the stabiliser are placed on the beating heart on both sides of the target coronary artery. The proximal parts are fixed to the operating table. Through the application of negative pressure, the target area of the heart is sufficiently immobilised to allow the safe construction of the anastomosis of the graft with the recipient artery.

On-pump technique: Conventional coronary artery surgery with cardiopulmonary bypass was accomplished with every effort to minimize the impact of cardiopulmonary bypass. Patients without diabetes received 1 gram of hydrocortisone sodium succinate (SoluCortef®, Pharmacia & Upjohn Co., USA) intravenously before of anesthesia. This procedure will be made only in the on-pump technique.
Intervention typeOther
Primary outcome measureThe following will be assessed at discharge and 5-year follow-up:
1. Incidence of cardiovascular mortality
2. Cerebrovascular accident
3. Non-fatal myocardial infarction
4. Refractory angina requiring revascularisation
Secondary outcome measuresThe following were assessed at discharge and at 5-year follow-up:
1. Non-cardiac mortality
2. Presence and severity of angina
3. Quality of life, using the 36-item Short Form health survey (SF-36)
4. Cost-effectiveness
Overall study start date31/01/2002
Overall study end date31/01/2010

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants311
Participant inclusion criteria1. Male or female, age 18 years or older
2. Patients with stable angina pectoris and/or documented ischemia due to multivessel disease and preserved ventricular function
3. Angiographically confirmed multivessel coronary artery disease (CAD) with >=70% lesions in at least two major epicardial vessels and at least two separate coronary artery territories (LAD, LCX and RCA)
4. Patients who are eligible for coronary surgery both with and without cardiopulmonary bypass circuit
5. Willing to comply with all follow-up study visits
6. Signed and received a copy of the informed consent

Note: Non-significant left main stenoses can be included
Participant exclusion criteria1. Age under 18 years
2. Severe congestive hearth failure, New York Heart Association (NYHA) Class III or IV, or pulmonary edema
3. Prior valve replacement or coronary artery bypass graft (CABG) surgery
4. Prior percutaneous coronary intervention (PCI) with stent implantation within 6 months
5. Prior stroke within 6 months or patients with stroke that occurred more than 6 months ago with significant residual neurological involvement, as reflected in a Rankin score >= 1
6. Need for concomitant major surgery e.g. valve replacement, resection ventricular aneurysm, congenital heart disease vascular surgery of the carotid artery, or thoracic-abdominal aorta
7. Concomitant medical disorders making clinical follow-up at least 5 years unlikely or impossible e.g. neoplastic, hepatic, or other severe disease
8. Q-wave myocardial infarction in the previous 6 weeks
9. Hemorrhagic diathesis or hypercoagulability
10. Thoracic deformations technically precluding surgery without extracorporeal circulation
11. Unable to give informed consent
Recruitment start date31/01/2002
Recruitment end date31/01/2010

Locations

Countries of recruitment

  • Brazil

Study participating centre

Av. Dr. Eneas Carvalho Aguiar 44 AB
Sao Paulo
05403000
Brazil

Sponsor information

Zerbini Foundation (Fundação Zerbini) (Brazil)
Charity

Av. Dr. Eneas Carvalho Aguiar 44 AB
Sala 114
Sao Paulo
05403-000
Brazil

Website http://www.incor.usp.br
ROR logo "ROR" https://ror.org/003c2h870

Funders

Funder type

Charity

Zerbini Foundation (Fundaciao Zerbini) (Brazil)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing planNot provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 05/08/2014 Yes No
Results article results 01/03/2015 Yes No
Results article Long-term analysis 19/12/2022 20/12/2022 Yes No

Editorial Notes

20/12/2022: Publication reference added.